Increased p53 Protein Associated with Aging in Human Diploid Fibroblasts
Abstract
Molecular changes associated with cellular aging in a strain of human diploid fibroblasts, IMR-90, were addressed by analyzing the expression of the tumor suppressor protein, p53. In all studies, IMR-90 cultures were characterized as "young" or "near-senescent" based on morphology, rate of population doubling, capacity for DNA synthesis, and presence of established markers for senescence. When p53 was immunoprecipitated by monoclonal antibodies and detected by Western immunoblot analysis, more protein per cell was detected in the near-senescent cultures. A greater than 10-fold increase in p53 protein was measured with the PAb 1801 (N-terminal-specific) anti-p53 antibody, whereas PAb 122 (C-terminal-specific) measured a 5-fold increase. Although near-senescent cultures demonstrated a higher level of p53 than young cells, these cultures had similar charges and molecular weight p53 isoforms when analyzed by two-dimensional Western blots. When p53 RNA was compared to total RNA there was a decrease in p53 RNA with age, but on a per cell basis p53 RNA was elevated. These results provide evidence for transcriptional regulation of p53 during aging and support the hypothesis that elevated levels of p53 protein may play a role in cellular senescence.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the cell senescence process, two main proteins, Rb and p53, are activated; their inactivation prevented senescence.
“In the cell senescence process, two main proteins, a tumor suppressor protein and critical cell cycle regulator Retinoblastoma protein (Rb) and p53 tumor suppressor protein are activated; their inactivation prevented senescence (Kulju and Lehman 1995).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Kulju and Lehman 1995
Cited by
Sorted by citations
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638 · see citing works
The signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046 · see citing works
“The p53 protein is stabilized and proceeds to activate its transcriptional targets, such as p21CIP1/WAF1 (Kulju & Lehman, 1995).”
BackgroundKregel, K. C., & Zhang, H. J. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00327.2006 · Cited by 883 · see citing works
“Evidence has shown that both p53 and Rb protein are activated when cells are in a senescent state (131, 182), while inactivation of these two proteins prevents senescence of human lung fibroblasts (280) and allows senescent cells to resume proliferation (81, 228).”
BackgroundSenescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826 · see citing works
“…and p21Cip1 is detected in a variety of senescent cells, and overexpression of telomerase leads to immortalization of human cells in culture (Kulju and Lehman 1995; Alcorta et al. 1996; Hara et al. 1996; Reznikoff et al. 1996; Shay and Bacchetti 1997; Bodnar et al. 1998; van Steensel et al.…”
BackgroundBrown, J. P., Wei, W., & Sedivy, J. M. (1997) · Science · doi:10.1126/science.277.5327.831 · Cited by 804 · see citing works
Proliferative capacity of the corneal endothelium
Joyce, N. C. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00065-4 · Cited by 613 · see citing works
Chen, Q. M., Bartholomew, J. C., Campisi, J., Acosta, M., REAGAN, J. D., & Ames, B. N. (1998) · Biochemical Journal · doi:10.1042/bj3320043 · Cited by 442 · see citing works
Vaziri, H., West, M. D., Allsopp, R., Davison, T. S., Wu, Y., Arrowsmith, C. H., Poirier, G. G., & Benchimol, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.6018 · Cited by 384 · see citing works
“…cells compared with young cells when extracts were immunoprecipitated with PAb1801 or PAb421 antibodiesand disruption of p53 protein function has been reported to extend the proliferative lifespan of human fibroblasts. prior to Western blotting (Kulju and Lehman, 1995; Vaziri and Benchimol, 1996).”
BackgroundRegulation of cellular senescence by p53
Itahana, K., Dimri, G., & Campisi, J. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02228.x · Cited by 365 · see citing works
“Campisi, unpublished results), although there is one report to the contrary [76].”
miR‐17, miR‐19b, miR‐20a, and miR‐106a are down‐regulated in human aging
Hackl, M., Brunner, S. M., Fortschegger, K., Schreiner, C., Mičutková, L., Mück, C., Laschober, G. T., Lepperdinger, G., Sampson, N., Berger, P., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00549.x · Cited by 356 · see citing works
“Thus, decreased miR-17-92 levels are consistent with the notion that, E2F family members decrease (Dimri et al., 1994), while p53 activity increases in senescence (Atadja et al., 1995; Kulju & Lehman, 1995).”
BackgroundWild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
Sugrue, M. M., Shin, D. Y., Lee, S. W., & Aaronson, S. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9648 · Cited by 290 · see citing works
A p53-independent Pathway for Activation of WAF1/CIP1 Expression Following Oxidative Stress
Russo, T., Zambrano, N., Esposito, F., Ammendola, R., Cimino, F., Fiscella, M., Jackman, J., O'Connor, P. M., Anderson, C. W., & Appella, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29386 · Cited by 246 · see citing works
Cellular Senescence: Molecular Mechanisms, In Vivo Significance, and Redox Considerations
Müller, M. K. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2104 · Cited by 237 · see citing works
“Initial evidence for the transcriptional regulation of p53 during replicative senescence was provided by Kulju and Lehman (221), who found p53 mRNA and p53 protein levels in the IMR-90 diploid fibroblast were increased severalfold in near-senescent cells compared with younger cells.”
Relevance of the p53–MDM2 axis to aging
Wu, D., & Prives, C. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.187 · Cited by 215 · see citing works
Webley, K., Bond, J. A., Jones, C. J., Blaydes, J. P., Craig, A., Hupp, T., & Wynford-Thomas, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2803-2808.2000 · Cited by 192 · see citing works
“We can only speculate that such changes were missed for technical reasons in previous studies, reflecting the inadvertant induction of a confounding DNA damage response by (32)P labeling (8) and/or the lack of resolution of the approaches used (1, 29).”
MethodMolecular bases of progeroid syndromes
Navarro, C. L., Cau, P., & Lévy, N. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl214 · Cited by 189 · see citing works
Changes of p53 in the Brains of Patients with Alzheimer's Disease
Kitamura, Y., Shimohama, S., Kamoshima, W., Matsuoka, Y., Nomura, Y., & Taniguchi, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6301 · Cited by 185 · see citing works
Chen, Q. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06640.x · Cited by 176 · see citing works
Seluanov, A., Gorbunova, V., Falcovitz, A., Sigal, A., Milyavsky, M., Zurer, I., Shohat, G., Goldfinger, N., & Rotter, V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1552-1564.2001 · Cited by 178 · see citing works
“Fourth, the DNA binding and transcriptional activities of p53 increase with cell age, and in most cases this occurs in the absence of any marked increase in the level of p53 (1, 4, 36, 47, 60).”
BackgroundBladier, C., Wolvetang, E. J., Hutchinson, P. E., de Haan, J. B., & Kola, I. (1997) · PubMed · Cited by 168 · see citing works
Jackson, J. G., & Pereira‐Smith, O. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1752 · Cited by 165 · see citing works
“For replicative senescence, one study found increased p53 protein (15); however, numerous others have found no change (12, 13, 16, 17).”
Uncoupling between Phenotypic Senescence and Cell Cycle Arrest in Aging p21-Deficient Fibroblasts
Dulić, V., Beney, G.-E., Frebourg, G., Drullinger, L. F., & Stein, G. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6741-6754.2000 · Cited by 149 · see citing works
“For example, if the aging process causes an increase in the amount of p53 (31) or in the activity of p53 (2), this proportional change should occur equally well in E6 cells, albeit starting from a much smaller amount of p53.”
BackgroundmiR-17–92 cluster: ups and downs in cancer and aging
Grillari, J., Hackl, M., & Grillari‐Voglauer, R. (2010) · Biogerontology · doi:10.1007/s10522-010-9272-9 · Cited by 143 · see citing works
“…senescent cells (Dimri et al. 1994), and p53, which is a decisive switch in aging and tumorigenesis (Rodier et al. 2007; Schmid et al. 2007) is increasingly active in senescence (Atadja et al. 1995; Kulju and Lehman 1995) and might thus contribute by actively repressing miR-17–92 (Yan et al. 2009).”
BackgroundGuide to collagen characterization for biomaterial studies
Abraham, L. C., Zuena, E., Pérez-Ramírez, B., & Kaplan, D. L. (2008) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.31078 · Cited by 140 · see citing works
Age Changes in Stem Cells of Murine Small Intestinal Crypts
Martin, K., Kirkwood, T. B. L., & Potten, C. S. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4001 · Cited by 135 · see citing works
Okamoto, K., Kashima, K., Pereg, Y., Ishida, M., Yamazaki, S., Nota, A., Teunisse, A., Migliorini, D., Kitabayashi, I., Marine, J.-C., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9608-9620.2005 · Cited by 129 · see citing works
“It was reported that increased activity of p53 is associated with cell senescence (2, 18).”
BackgroundMasuda, A., & Takahashi, T. (2002) · Oncogene · doi:10.1038/sj.onc.1205566 · Cited by 132 · see citing works
“…and cease proliferation, which is accompanied by activation of p53 as well as increased expression of p21, p16INK4A and p14ARF (Atadja et al., 1995; Kulju and Lehman, 1995; Alcorta et al., 1996; Dimri et al., 2000). p53- and Rb-inactivating oncoproteins of viral origin such as SV40 large T,…”
BackgroundRole of fibroblast-derived growth factors in regulating hyperpigmentation of solar lentigo
Kovacs, D., Cardinali, G., Aspite, N., Cota, C., Luzi, F., Bellei, B., Briganti, S., Amantea, A., Torrisi, M. R., & Picardo, M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09946.x · Cited by 121 · see citing works
Nuclear factor kappaB subunits induce epithelial cell growth arrest.
Seitz, C. S., Deng, H., Hinata, K., Lin, Q., & Khavari, P. A. (2000) · PubMed · Cited by 119 · see citing works
Are there roles for brain cell senescence in aging and neurodegenerative disorders?
Tan, F. C. C., Hutchison, E. R., Eitan, E., & Mattson, M. P. (2014) · Biogerontology · doi:10.1007/s10522-014-9532-1 · Cited by 116 · see citing works
Cakouros, D., Isenmann, S., Cooper, L., Zannettino, A. C. W., Anderson, P. J., Glackin, C. A., & Gronthos, S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06315-11 · Cited by 115 · see citing works
Byun, H.-O., Lee, Y.-K., Kim, J.-M., & Yoon, G. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.10.122 · Cited by 115 · see citing works
Cellular Senescence - its role in cancer and the response to ionizing radiation
Sabin, R. J., & Anderson, R. M. (2011) · Genome Integrity · doi:10.1186/2041-9414-2-7 · Cited by 116 · see citing works
“involving p53, and p16INK4A/pRb [5,6].”
Premature senescence of endothelial cells: Methusaleh's dilemma
Chen, J., & Goligorsky, M. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01103.2005 · Cited by 110 · see citing works
“Overexpression of the tumor suppressor p53 results in transcriptional activation of many proteins, including p21, an inhibitor of the cyclin E/Cdk2 complex (87).”
BackgroundMüller, M. K., Li, Z., & Maitz, P. (2009) · Burns · doi:10.1016/j.burns.2008.11.010 · Cited by 105 · see citing works
“The molecular mechanisms associated with cellular senescence are well defined [15] with cell cycle arrest resulting from activation of either the telomere-dependent p53/p21 [16,17] or the telomere-independent Erk/p38 pathways [18].”
BackgroundQin, J., Chaturvedi, V., Denning, M. F., Bacon, P. E., Panella, J., Choubey, D., & Nickoloff, B. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205404 · Cited by 106 · see citing works
Nishio, K., & Inoue, A. (2005) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0766-5 · Cited by 100 · see citing works
“It is known that senescent human fibroblasts increase in mRNA and protein levels of p53 (Kulju and Lehman 1995).”
BackgroundInfluentialSubtractive Hybridization of mRNA from early passage and senescent endothelial cells
Grillari, J., Hohenwarter, O., Grabherr, R. M., & Katinger, H. W. D. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00080-2 · Cited by 96 · see citing works
Sp1-Mediated Transcription of the Werner Helicase Gene Is Modulated by Rb and p53
Yamabe, Y., Shimamoto, A., Goto, M., Yokota, J., Sugawara, M., & Furuichi, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6191 · Cited by 91 · see citing works
“However, Kulju and Lehman (22) reported that the steady-state level of p53 protein increases in the near-senescent human diploid fibroblast cells; also, Sugrue et al. (39) found that the overexpression of wild-type p53 in human EJ cells triggers a rapid onset of G1 and G2/M growth arrest, which is irreversible and res…”
BackgroundReplicative senescence revisited.
Marcotte, R., & Wang, E. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.7.b257 · Cited by 86 · see citing works
Dysfunction of the MDM2/p53 axis is linked to premature aging
Lessel, D., Wu, D., Trujillo, C., Ramezani, T., Lessel, I., Alwasiyah, M. K., Saha, B., Hisama, F. M., Rading, K., Goebel, I., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92171 · Cited by 83 · see citing works
“For example, p53 protein levels accumulate in aged, “near-senescent” human fibroblasts (11), but decline in aged mouse populations (12).”
Byun, H., Lee, Y., Kim, J., & Yoon, G. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.11.122 · Cited by 83 · see citing works
“These include p53 (35, 50), p21 (36), p15 (37, 38), p16 (39), vimentin (51),”
BackgroundReplicative Senescence in Human Uroepithelial Cells
Puthenveettil, J. A., Burger, M. S., & Reznikoff, C. A. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4737-2_7 · Cited by 79 · see citing works
Cellular Senescence: Ex Vivo p53‐Dependent Asymmetric Cell Kinetics
Rambhatla, L., Bohn, S. A., Stadler, P. B., Boyd, J. T., Coss, R. A., & Sherley, J. L. (2001) · BioMed Research International · doi:10.1155/s1110724301000079 · Cited by 74 · see citing works
“p53 protein expression [32] and transcriptional regulation activity [33, 34] are elevated in senescent cells; and p53 gene mutation is frequently associated with spontaneous immortalization of cells in culture [4, 35, 36].”
BackgroundYang, X., He, Z., Xin, B., & Cao, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203515 · Cited by 71 · see citing works
“The increased expressions of p53, p21, and p16 are detected in human cells which have undergone senescence (Kulju and Lehman, 1995; Alcorta et al., 1996).”
BackgroundThe intrinsic stiffness of human trabecular meshwork cells increases with senescence
Morgan, J. T., Raghunathan, V. K., Chang, Y.-R., Murphy, C. J., & Russell, P. (2015) · Oncotarget · doi:10.18632/oncotarget.3798 · Cited by 69 · see citing works
“In these cultures, the cells took on an enlarged, flattened morphology, typical of senescent cells [83-88].”
BackgroundHay, J. G., Shapiro, N., Sauthoff, H., et al. (1999) · Human Gene Therapy · doi:10.1089/10430349950018652 · Cited by 71 · see citing works
“IMR90 cells are normal lung fibroblasts (Kulju and Lehman, 1995).”
Liang, S., OHTSUKI, Y., Furihata, M., et al. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050327 · Cited by 67 · see citing works
“Wild-type p53 might also be induced in response to the increased DNA damage associated with ageing [11, 23 ].”
BackgroundKaur, K., Rani, G., Widodo, N., et al. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.07.015 · Cited by 65 · see citing works
Endothelial Progenitor Cells Dysfunction and Senescence: Contribution to Oxidative Stress
Imanishi, T., Tsujioka, H., & Akasaka, T. (2008) · Current Cardiology Reviews · doi:10.2174/157340308786349435 · Cited by 64 · see citing works
“Other biomarkers include increased expression of p53, p21, and p16 [70-73].”
BackgroundKim, K., Park, G., Lim, Y.-B., Rue, S.-W., Jung, J., Sonn, J., Bae, Y., Park, J., & Lee, Y. S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.108 · Cited by 65 · see citing works
Vaziri, H., & Benchimol, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203016 · Cited by 59 · see citing works
“…activity of p53, p21 and another CDK inhibitor, p16INK4a, is detected in senescent cells lending further support to the importance of the p53 and Rb pathways in senescence (Atadja et al., 1995; Noda et al., 1994; Kulju and Lehman, 1995; Vaziri et al., 1997; Alcorta et al., 1996; Hara et al., 1996).”
Backgroundp53-dependent senescence delays Eμ-myc-induced B-cell lymphomagenesis
Post, S. M., Quintás‐Cardama, A., Terzian, T., Smith, C., Eischen, C. M., & Lozano, G. (2009) · Oncogene · doi:10.1038/onc.2009.423 · Cited by 58 · see citing works
Flex, E., Martinelli, S., Dijck, A. V., Ciolfi, A., Cecchetti, S., Coluzzi, E., Pannone, L., Andreoli, C., Radio, F. C., Pizzi, S., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.07.007 · Cited by 58 · see citing works
HDACs and the senescent phenotype of WI-38 cells
Place, R. F., Noonan, E. J., & Giardina, C. A. (2005) · BMC Cell Biology · doi:10.1186/1471-2121-6-37 · Cited by 57 · see citing works
“quent growth arrest [39,40].”
Tsirpanlis, G. I. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.07.035 · Cited by 54 · see citing works
The LNT model for cancer induction is not supported by radiobiological data
Scott, B. R., & Tharmalingam, S. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.01.013 · Cited by 56 · see citing works
Zmijewski, J. W., & Jope, R. S. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00117.x · Cited by 54 · see citing works
“…Western blot analyses revealed markers typical of senescence in old cells, including increased levels of p16 ink4a , p21 and nuclear p53 (Shay et al. , 1991; Kulju & Lehman, 1995; Tahara et al. , 1995; Alcorta et al. , 1996; Bond et al. , 1996), and a reduced level of HSP70 (Bonelli et al. , 1999).”
BackgroundAccelerated Development and Aging of the Immune System in p53-Deficient Mice
Ohkusu‐Tsukada, K., Tsukada, T., & Isobe, K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1966 · Cited by 56 · see citing works
“Recently, the expression and transcriptional activity of p53 were reported to be increased in senescent fibroblasts (3, 4), while the induction of p53 expression has been reported to be impaired in activated T cells in certain elderly people (5).”
BackgroundGorbunova, V. A., Seluanov, A., & Pereira‐Smith, O. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212944200 · Cited by 56 · see citing works
DNA Topoisomerase Inhibitors Induce Reversible Senescence in Normal Human Fibroblasts
Michishita, E., Nakabayashi, K., Ogino, H., Suzuki, T., Fujii, M., & Ayusawa, D. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9832 · Cited by 55 · see citing works
MicroRNAs in human skin ageing
Mancini, M., Lena, A. M., Saintigny, G., Mahé, C., Daniele, N. D., Melino, G., & Candi, E. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.04.003 · Cited by 53 · see citing works
Zhao, W., Lin, Z. X., & Zhang, Z. (2004) · Cell Research · doi:10.1038/sj.cr.7290203 · Cited by 51 · see citing works
Regulation of p53 during senescence in normal human keratinocytes
Kim, R. H., Kang, M., Kim, T., Yang, P., Bae, S., Williams, D. W., Phung, S., Shin, K., Hong, C., & Park, N. (2015) · Aging Cell · doi:10.1111/acel.12364 · Cited by 49 · see citing works
“During replicative senescence, p53 expression level is reported to be similar in young and senescent fibroblasts (Atadja et al., 1995), while others report that its expression level increases in human diploid fibroblasts (Kulju & Lehman, 1995).”
BackgroundProliferative lifespan checkpoints: Cell-type specificity and influence on tumour biology
Wynford‐Thomas, D. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00064-6 · Cited by 48 · see citing works
Sokolov, M. V., Smirnova, N. A., Camerini‐Otero, R. D., Neumann, R. D., & Panyutin, I. G. (2006) · Gene · doi:10.1016/j.gene.2006.06.008 · Cited by 47 · see citing works
Melanomagenesis: Overcoming the barrier of melanocyte senescence
Ha, L., Merlino, G. T., & Sviderskaya, E. V. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6230 · Cited by 46 · see citing works
Expression of an IFN-Inducible Cellular Senescence Gene, IFI16, Is Up-Regulated by p53
Song, L. L., Alimirah, F., Panchanathan, R., Xin, H., & Choubey, D. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0208 · Cited by 45 · see citing works
“These studies (8-12) have suggested a role for p53 in the onset”
BackgroundInfluentialSenescence and immortalization of human cells
Duncan, E. L., Wadhwa, R., & Kaul, S. C. (2000) · Biogerontology · doi:10.1023/a:1010000132671 · Cited by 45 · see citing works
“While it remains controversial as to whether the cellular level of p53 protein changes as cells enter senescence (Afshari et al. 1993; Atadja et al. 1995; Kulju and Lehman 1995; Vaziri and Benchimol 1996), the transcriptional activation and the DNA binding activities of the protein both increase as cells near senescen…”
BackgroundGenes Involved in the Control of Cellular Proliferative Potentiala
Reddel, R. R. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb09887.x · Cited by 43 · see citing works
Dorszewska, J., & Adamczewska-Goncerzewicz, Z. (2003) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2003.10.005 · Cited by 39 · see citing works
Słomnicki, Ł. P., & Leśniak, W. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22434 · Cited by 36 · see citing works
Isolation and characterization of outer root sheath melanocytes of human hair follicles
Na, G. Y., Paek, S. H., Park, B. C., Kim, D. W., Lee, W. J., Lee, S. J., Kim, M. K., & Kim, J. C. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07502.x · Cited by 36 · see citing works
Kang, M., & Park, M.-H. (2001) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411010120010301 · Cited by 34 · see citing works
ESTABROOKS, S. L. (2007) · Journal of Shellfish Research · doi:10.2983/0730-8000(2007)26[307:tproti]2.0.co;2 · Cited by 31 · see citing works
“…between telomere loss and cell senescence has not been elucidated, it is known that the cell cycle control protein, p53, is located near telomeres (Levine et al. 1993), and other studies have shown a relationship between telomere loss and aging (Kulju & Lehman 1995, Vaziri & Benchimol 1996,…”
BackgroundKim, S. S., Shetty, K., Katuri, V., Kitisin, K., Baek, H. J., Tang, Y., Marshall, B., Johnson, L. B., Mishra, B., & Mishra, L. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.236 · Cited by 34 · see citing works
“Senescent cells contain an activated p53 transcription factor [38,39] and elevated levels of p21 [40].”
BackgroundThe membrane hypothesis of aging: its relevance to recent progress in genetic research
Zs.-Nagy, I. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050157 · Cited by 31 · see citing works
Proteomics in experimental gerontology
Dierick, J., Dieu, M., Remacle, J., Raes, M. J., Roepstorff, P., & Toussaint, O. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00004-9 · Cited by 31 · see citing works
Garkavtsev, I., Hull, C. M., & Riabowol, K. T. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(97)00086-7 · Cited by 29 · see citing works
p53-Rb signaling pathway is involved in tubular cell senescence in renal ischemia/reperfusion injury
Li, K., Du, X., He, Y., LIN, Z., JVRONG, Y., RUIHUA, S., & Chen, L. (2007) · Biocell · doi:10.32604/biocell.2007.31.213 · Cited by 28 · see citing works
“The p53 protein is stabilized and proceeds to activate its transcriptional targets, such as p21 (Kulju and Lehman, 1995).”
BackgroundOkonkwo, U. C., Ohagwu, C. C., Aronu, M. E., Okafor, C. E., Idumah, C. I., Okokpujie, I. P., Chukwu, N. N., & Chukwunyelu, C. E. (2022) · Journal of Environmental Radioactivity · doi:10.1016/j.jenvrad.2022.106984 · Cited by 26 · see citing works
Accumulation of annexin A5 at the nuclear envelope is a biomarker of cellular aging
Klement, K., Melle, C., Murzik, U., Diekmann, S., Norgauer, J., & Hemmerich, P. H. (2012) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2012.06.003 · Cited by 24 · see citing works
Aging clock: the watchmaker's masterpiece
Ishikawa, F. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050034 · Cited by 24 · see citing works
Cyclooxygenase-2 inhibitors modulate skin aging in a catalytic activity-independent manner
Lee, M. E., Kim, S. R., Lee, S., Jung, Y., Choi, S. S., Kim, W. J., & Han, J. A. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.9.061 · Cited by 22 · see citing works
“In general, the activity of p53 increases in the course of cellular senescence with or without an elevation of p53 expression (Atadja et al., 1995; Kulju and Lehman, 1995).”
BackgroundGastrin-Releasing Peptide Receptor Knockdown Induces Senescence in Glioblastoma Cells
Menegotto, P. R., Lopez, P. L. D. C., Souza, B. K., de Farias, C. B., Filippi‐Chiela, E. C., Vieira, I. A., Schwartsmann, G., Lenz, G., & Roesler, R. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9696-6 · Cited by 22 · see citing works
“GRPR may play an inhibitory role on p53 and p21 function resulting in inhibition of cell cycle arrest and senescence [25, 35, 36].”
BackgroundNickels, A., Selter, H., Pfreundschuh, M. G., et al. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.8.654 · Cited by 22 · see citing works
Jie, B., Weilong, C., Cai, M., Xu, F., Xinghua, L., Junhua, C., Guobin, W., Tao, K., & Xiaoming, S. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.011 · Cited by 21 · see citing works
Ukraintseva, S. V., & YASHIN, A. I. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1299.089 · Cited by 20 · see citing works
Enhancement of Fas-mediated apoptosis in ageing human keratinocytes
Wang, X., Brégégère, F. M., Soroka, Y., Kayat, A., Redziniak, G., & Milner, Y. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2003.12.007 · Cited by 19 · see citing works
Ma, W., Hommel, C., Brenneisen, P., Peters, T., Smit, N. P. M., Sedivy, J. M., Scharffetter‐Kochanek, K., & Wlaschek, M. (2003) · Experimental Dermatology · doi:10.1034/j.1600-0625.2003.00024.x · Cited by 19 · see citing works
“Accordingly, Kulju and Lehmann (34) demonstrated an increase in p53 mRNA and protein expression in replicative-senescent fibroblasts.”
BackgroundMitteldorf, J. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918120106 · Cited by 16 · see citing works
Ukraintseva, S. V., & YASHINA, A. I. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1297.032 · Cited by 17 · see citing works
Xie, X., Wang, Y., Xia, Y., & Mao, Y. (2019) · Bioscience Reports · doi:10.1042/bsr20190433 · Cited by 18 · see citing works
DECREASE IN P53 PROTEIN IN CULTURED CARDINAL LIGAMENT FIBROBLASTS FROM PATIENTS WITH PROLAPSUS UTERI
Yamamoto, M., Aoyagi, M., Akazawa, K., Tajima, S., & YAMAMOTO, K. (1998) · Cell Biology International · doi:10.1006/cbir.1997.0207 · Cited by 17 · see citing works
Kim, H.-S., Heo, J., Park, S., Shin, J.-Y., Kang, H., Kim, M.-J., Kim, S. C., Kim, J., Park, J., & Lee, J. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3094-9 · Cited by 16 · see citing works
“Increased p53 protein in senescent cells has been implicated for transcriptional activation of p21 by p53 [21].”
BackgroundReplicative enzymes, DNA polymerase alpha (pol α), and in vitro ageing
Srivastava, V. K., & Busbee, D. L. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.09.008 · Cited by 15 · see citing works
Yamamoto, M., Akazawa, K., Aoyagi, M., & Yamamoto, K. (2000) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(00)00121-4 · Cited by 15 · see citing works
Relationship of telomeres and p53 in aging bovine corneal endothelial cell cultures.
Whikehart, D. R., Register, S. J., Chang, Q., & Montgomery, B. (2000) · PubMed · Cited by 15 · see citing works
Leiszter, K., Galamb, O., Sípos, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074140 · Cited by 13 · see citing works
Telomere dynamics: the means to an end
Matulić, M., Sopta, M., & Rubelj, I. (2007) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00452.x · Cited by 12 · see citing works
“These modifications contribute to displacement of mdm2 from p53 allowing its stabilization and activation (Kulju & Lehman 1995; Vaziri et al. 1997; Gire et al. 2004; Artandi & Attardi 2005).”
Background
- Authors
- Kulju, K. S., & Lehman, J. M.
- Affiliations
- Albany Medical College (US)
- ORCID
- Lehman, John M.
- Venue
- Experimental Cell Research
- Publisher
- Elsevier BV
- Published
- 1995-04
- Volume
- 217
- Issue
- 2
- Pages
- 336-345
- ISSN
- 0014-4827 (ISSN-L)
- OpenAlex
- W2062636398
- Cited by
- 155
- References
- 0
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 4 · 2022: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 5 · 2013: 3 · 2012: 8
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental Cell Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-41608)
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p53, cellular senescence, cellular aging, human diploid fibroblasts, IMR-90 cells, p53 protein levels, p53 isoforms, tumor suppressor proteins
- MeSH terms
- Cell Cycle, Cell Line, Diploidy, Fibroblasts, Humans, RNA, Messenger, Electrophoresis, Gel, Two-Dimensional, Tumor Suppressor Protein p53, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review